Regenxbio Share Price (NASDAQ: RGNX)
$8.94
Last updated on
Check the interactive Regenxbio Stock chart to analyse performance
Regenxbio stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$8.70Today's High:$8.94
2.68%
Downside
Day's Volatility :2.68%
Upside
0.0%
- 52 Weeks Low:$5.0452 Weeks High:$13.48
43.68%
Downside
52 Weeks Volatility :62.65%
Upside
33.68%
Regenxbio Stock Returns
Regenxbio Inc Key Stats
Check Regenxbio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Regenxbio Stock including INR - Dollar returns
The Regenxbio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Regenxbio investment value today
Current value as on today
₹84,120
Returns
Returns from Regenxbio Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Regenxbio Stock
Global Institutional Holdings in Regenxbio Inc
Name
Holdings %
BlackRock Inc
10.80%
Redmile Group, LLC
9.45%
JPMorgan Chase & Co
8.64%
Vanguard Group Inc
6.77%
Morgan Stanley - Brokerage Accounts
4.09%
Goldman Sachs Group Inc
3.53%
Analyst Recommendation on Regenxbio Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 18 Wall street analysts offering stock ratings for Regenxbio(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Regenxbio Share Price Target
What analysts predicted
Upside of 232.77%
Target:
$29.75
Current:
$8.94
Regenxbio share price target is $29.75, a slight Upside of 232.77% compared to current price of $8.94 as per analysts' prediction.
Regenxbio Stock Insights
Price Movement
In the last 6 months, RGNX stock has moved up by 36.1%Decreasing Revenue
Revenue is down for the last 2 quarters, 89.01M → 21.35M (in $), with an average decrease of 76.0% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, 6.08M → -70.87M (in $), with an average decrease of 1265.1% per quarterRGNX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 96.7%RGNX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 185.7%Price to Sales
ForRGNX every $1 of sales, investors are willing to pay $2.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Regenxbio Inc Financials
Regenxbio Technicals Summary
Sell
Neutral
Buy
Regenxbio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Regenxbio Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 9.16% | 51.01% | -21.16% | -70.2% | -69.67% |
 | 3.92% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -15.42% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 11.08% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 12.06 | NA | 0.26 | -2.13 | -0.62 | -0.18 | NA | 4.24 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $455.1M | -69.67% | 12.06 | -112.7% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Regenxbio Inc
Key Management of Regenxbio Inc
Important FAQs about investing in RGNX Stock from India :
What is Regenxbio share price today?
Regenxbio share price today is $8.94 as on at the close of the market. Regenxbio share today touched a day high of $8.94 and a low of $8.70.
What is the 52 week high and 52 week low for Regenxbio share?
Regenxbio share touched a 52 week high of $13.48 and a 52 week low of $5.04. Regenxbio stock price today i.e. is closed at $8.94, lower by 33.68% versus the 52 week high.
How to invest in Regenxbio Stock (RGNX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Regenxbio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regenxbio Shares that will get you 0.1678 shares as per Regenxbio share price of $8.94 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Regenxbio Stock (RGNX) from India?
Indian investors can start investing in Regenxbio (RGNX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Regenxbio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Regenxbio share’s latest price of $8.94 as on August 30, 2025 at 1:29 am IST, you will get 1.1186 shares of Regenxbio. Learn more about
fractional shares .
What are the returns that Regenxbio has given to Indian investors in the last 5 years?
Regenxbio stock has given -69.67% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%